Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process

Grants

Funding Acknowledgements

This study was funded by MS Research Australia. All participants of the Australian MS Longitudinal Study are sincerely thanked for their support and willingness to complete surveys.